Literature DB >> 29152485

Patient-derived xenografts, a multi-faceted in vivo model enlightening research on rare liver cancer biology.

Massimo Moro1, Michela Casanova2, Luca Roz1.   

Abstract

Entities:  

Year:  2017        PMID: 29152485      PMCID: PMC5673757          DOI: 10.21037/hbsn.2017.06.03

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN: 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  10 in total

1.  Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine.

Authors:  Chantal Pauli; Benjamin D Hopkins; Davide Prandi; Reid Shaw; Tarcisio Fedrizzi; Andrea Sboner; Verena Sailer; Michael Augello; Loredana Puca; Rachele Rosati; Terra J McNary; Yelena Churakova; Cynthia Cheung; Joanna Triscott; David Pisapia; Rema Rao; Juan Miguel Mosquera; Brian Robinson; Bishoy M Faltas; Brooke E Emerling; Vijayakrishna K Gadi; Brady Bernard; Olivier Elemento; Himisha Beltran; Francesca Demichelis; Christopher J Kemp; Carla Grandori; Lewis C Cantley; Mark A Rubin
Journal:  Cancer Discov       Date:  2017-03-22       Impact factor: 39.397

2.  Integrated next-generation sequencing and avatar mouse models for personalized cancer treatment.

Authors:  Elena Garralda; Keren Paz; Pedro P López-Casas; Siân Jones; Amanda Katz; Lisa M Kann; Fernando López-Rios; Francesca Sarno; Fátima Al-Shahrour; David Vasquez; Elizabeth Bruckheimer; Samuel V Angiuoli; Antonio Calles; Luis A Diaz; Victor E Velculescu; Alfonso Valencia; David Sidransky; Manuel Hidalgo
Journal:  Clin Cancer Res       Date:  2014-03-14       Impact factor: 12.531

3.  High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response.

Authors:  Hui Gao; Joshua M Korn; Stéphane Ferretti; John E Monahan; Youzhen Wang; Mallika Singh; Chao Zhang; Christian Schnell; Guizhi Yang; Yun Zhang; O Alejandro Balbin; Stéphanie Barbe; Hongbo Cai; Fergal Casey; Susmita Chatterjee; Derek Y Chiang; Shannon Chuai; Shawn M Cogan; Scott D Collins; Ernesta Dammassa; Nicolas Ebel; Millicent Embry; John Green; Audrey Kauffmann; Colleen Kowal; Rebecca J Leary; Joseph Lehar; Ying Liang; Alice Loo; Edward Lorenzana; E Robert McDonald; Margaret E McLaughlin; Jason Merkin; Ronald Meyer; Tara L Naylor; Montesa Patawaran; Anupama Reddy; Claudia Röelli; David A Ruddy; Fernando Salangsang; Francesca Santacroce; Angad P Singh; Yan Tang; Walter Tinetto; Sonja Tobler; Roberto Velazquez; Kavitha Venkatesan; Fabian Von Arx; Hui Qin Wang; Zongyao Wang; Marion Wiesmann; Daniel Wyss; Fiona Xu; Hans Bitter; Peter Atadja; Emma Lees; Francesco Hofmann; En Li; Nicholas Keen; Robert Cozens; Michael Rugaard Jensen; Nancy K Pryer; Juliet A Williams; William R Sellers
Journal:  Nat Med       Date:  2015-10-19       Impact factor: 53.440

Review 4.  Disease Modeling in Stem Cell-Derived 3D Organoid Systems.

Authors:  Devanjali Dutta; Inha Heo; Hans Clevers
Journal:  Trends Mol Med       Date:  2017-03-21       Impact factor: 11.951

Review 5.  Interrogating open issues in cancer precision medicine with patient-derived xenografts.

Authors:  Annette T Byrne; Denis G Alférez; Frédéric Amant; Daniela Annibali; Joaquín Arribas; Andrew V Biankin; Alejandra Bruna; Eva Budinská; Carlos Caldas; David K Chang; Robert B Clarke; Hans Clevers; George Coukos; Virginie Dangles-Marie; S Gail Eckhardt; Eva Gonzalez-Suarez; Els Hermans; Manuel Hidalgo; Monika A Jarzabek; Steven de Jong; Jos Jonkers; Kristel Kemper; Luisa Lanfrancone; Gunhild Mari Mælandsmo; Elisabetta Marangoni; Jean-Christophe Marine; Enzo Medico; Jens Henrik Norum; Héctor G Palmer; Daniel S Peeper; Pier Giuseppe Pelicci; Alejandro Piris-Gimenez; Sergio Roman-Roman; Oscar M Rueda; Joan Seoane; Violeta Serra; Laura Soucek; Dominique Vanhecke; Alberto Villanueva; Emilie Vinolo; Andrea Bertotti; Livio Trusolino
Journal:  Nat Rev Cancer       Date:  2017-01-20       Impact factor: 60.716

6.  Metabolic Evaluation of Non-Small Cell Lung Cancer Patient-Derived Xenograft Models Using 18F-FDG PET: A Potential Tool for Early Therapy Response.

Authors:  Silvia Valtorta; Massimo Moro; Giovanna Prisinzano; Giulia Bertolini; Monica Tortoreto; Isabella Raccagni; Ugo Pastorino; Luca Roz; Gabriella Sozzi; Rosa Maria Moresco
Journal:  J Nucl Med       Date:  2016-10-20       Impact factor: 10.057

7.  Prognostic factors of overall survival in children and adolescents enrolled in dose-finding trials in Europe: An Innovative Therapies for Children with Cancer study.

Authors:  Fernando Carceller; Francisco J Bautista; Irene Jiménez; Raquel Hladun-Álvaro; Cécile Giraud; Luca Bergamaschi; Madhumita Dandapani; Isabelle Aerts; François Doz; Didier Frappaz; Michela Casanova; Bruce Morland; Darren R Hargrave; Lynley V Marshall; Gilles Vassal; Andrew D J Pearson; Birgit Geoerger; Lucas Moreno
Journal:  Eur J Cancer       Date:  2016-09-21       Impact factor: 9.162

8.  Patient-derived mouse xenografts from pediatric liver cancer predict tumor recurrence and advise clinical management.

Authors:  Delphine Nicolle; Monique Fabre; Marina Simon-Coma; Aurore Gorse; Roland Kappler; Lara Nonell; Mar Mallo; Hazar Haidar; Olivier Déas; Charlotte Mussini; Catherine Guettier; Marie-José Redon; Laurence Brugières; Maria Rosa Ghigna; Elie Fadel; Louise Galmiche-Rolland; Christophe Chardot; Jean-Gabriel Judde; Carolina Armengol; Sophie Branchereau; Stefano Cairo
Journal:  Hepatology       Date:  2016-06-16       Impact factor: 17.425

Review 9.  Patient-derived xenograft models: an emerging platform for translational cancer research.

Authors:  Manuel Hidalgo; Frederic Amant; Andrew V Biankin; Eva Budinská; Annette T Byrne; Carlos Caldas; Robert B Clarke; Steven de Jong; Jos Jonkers; Gunhild Mari Mælandsmo; Sergio Roman-Roman; Joan Seoane; Livio Trusolino; Alberto Villanueva
Journal:  Cancer Discov       Date:  2014-07-15       Impact factor: 39.397

Review 10.  Patient-derived xenografts of non small cell lung cancer: resurgence of an old model for investigation of modern concepts of tailored therapy and cancer stem cells.

Authors:  Massimo Moro; Giulia Bertolini; Monica Tortoreto; Ugo Pastorino; Gabriella Sozzi; Luca Roz
Journal:  J Biomed Biotechnol       Date:  2012-04-04
  10 in total
  2 in total

1.  Programmed cell death protein 1/programmed death ligand-1 checkpoint blockade meets patient-derived organoids.

Authors:  Lejia Sun; Huayu Yang; Yilei Mao
Journal:  Ann Transl Med       Date:  2019-12

2.  Patient-derived organoids: a promising model for personalized cancer treatment.

Authors:  Huayu Yang; Lejia Sun; Meixi Liu; Yilei Mao
Journal:  Gastroenterol Rep (Oxf)       Date:  2018-10-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.